{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:12:34Z","timestamp":1740107554336,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070814"],"award-info":[{"award-number":["82070814"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Project of Jiangsu Health Commission","award":["H2019043"],"award-info":[{"award-number":["H2019043"]}]},{"name":"Scientific Research Project of Suzhou Health Commission","award":["SYS2019970"],"award-info":[{"award-number":["SYS2019970"]}]},{"name":"Open project of the State Key Laboratory of Radiation Medicine and Radiation Protection jointly built by the Ministry and the province","award":["GZK1202025"],"award-info":[{"award-number":["GZK1202025"]}]},{"name":"Second Affiliated Hospital of Soochow University Science Foundation","award":["SDFEYQN1912"],"award-info":[{"award-number":["SDFEYQN1912"]}]},{"name":"Suzhou Science and Education Health Project","award":["kjxw2019015"],"award-info":[{"award-number":["kjxw2019015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00592-021-01711-z","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T03:37:56Z","timestamp":1619149076000},"page":"1239-1249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Decreased expression of programmed death-1 on CD8+ effector memory T lymphocytes correlates with the pathogenesis of type 1 diabetes"],"prefix":"10.1007","volume":"58","author":[{"given":"Yimei","family":"Shan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sicheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4329-9471","authenticated-orcid":false,"given":"Chen","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"issue":"10138","key":"1711_CR1","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","volume":"391","author":"LA DiMeglio","year":"2018","unstructured":"DiMeglio LA, Evans-Molina C, Oram RA (2018) Type 1 diabetes. Lancet (London, England) 391(10138):2449\u20132462","journal-title":"Lancet (London, England)"},{"key":"1711_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2013.12.003","volume":"50","author":"G Sarikonda","year":"2014","unstructured":"Sarikonda G, Pettus J, Phatak S et al (2014) CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes. J Autoimmun 50:77\u201382","journal-title":"J Autoimmun"},{"issue":"20","key":"1711_CR3","doi-asserted-by":"publisher","first-page":"eaao4013","DOI":"10.1126\/sciimmunol.aao4013","volume":"3","author":"S Culina","year":"2018","unstructured":"Culina S, Lalanne AI, Afonso G et al (2018) Islet-reactive CD8 T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci Immunol 3(20):eaao4013","journal-title":"Sci Immunol"},{"issue":"3","key":"1711_CR4","doi-asserted-by":"publisher","first-page":"916","DOI":"10.2337\/db14-0332","volume":"64","author":"A Skowera","year":"2015","unstructured":"Skowera A, Ladell K, McLaren JE et al (2015) Beta-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure. Diabetes 64(3):916\u2013925","journal-title":"Diabetes"},{"issue":"2","key":"1711_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","volume":"48","author":"BV Kumar","year":"2018","unstructured":"Kumar BV, Connors TJ, Farber DL (2018) Human T cell development, localization, and function throughout life. Immunity 48(2):202\u2013213","journal-title":"Immunity"},{"issue":"7685","key":"1711_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature24633","volume":"552","author":"RS Akondy","year":"2017","unstructured":"Akondy RS, Fitch M, Edupuganti S et al (2017) Origin and differentiation of human memory CD8 T cells after vaccination. Nature 552(7685):362\u2013367","journal-title":"Nature"},{"issue":"7685","key":"1711_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nature25144","volume":"552","author":"B Youngblood","year":"2017","unstructured":"Youngblood B, Hale JS, Kissick HT et al (2017) Effector CD8 T cells dedifferentiate into long-lived memory cells. Nature 552(7685):404\u2013409","journal-title":"Nature"},{"issue":"10","key":"1711_CR8","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"L Gattinoni","year":"2011","unstructured":"Gattinoni L, Lugli E, Ji Y et al (2011) A human memory T cell subset with stem cell-like properties. Nat Med 17(10):1290\u20131297","journal-title":"Nat Med"},{"issue":"6754","key":"1711_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto F, Lenig D, F\u00f6rster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401(6754):708\u2013712","journal-title":"Nature"},{"issue":"6","key":"1711_CR10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1084\/jem.20161760","volume":"214","author":"HA Abdelsamed","year":"2017","unstructured":"Abdelsamed HA, Moustaki A, Fan Y et al (2017) Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis. J Exp Med 214(6):1593\u20131606","journal-title":"J Exp Med"},{"key":"1711_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12026-013-8448-1","volume":"57","author":"P Devarajan","year":"2013","unstructured":"Devarajan P, Chen Z (2013) Autoimmune effector memory T cells: the bad and the good. Immunol Res 57:12\u201322","journal-title":"Immunol Res"},{"issue":"2","key":"1711_CR12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4049\/jimmunol.1302100","volume":"192","author":"J Chee","year":"2014","unstructured":"Chee J, Ko HJ, Skowera A et al (2014) Effector-memory T cells develop in islets and report islet pathology in type 1 diabetes. J Immunol 192(2):572\u2013580","journal-title":"J Immunol"},{"issue":"11","key":"1711_CR13","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","volume":"11","author":"Y Ishida","year":"1992","unstructured":"Ishida Y, Agata Y, Shibahara K, Honjo T (1992) Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 11(11):3887\u20133895","journal-title":"EMBO J"},{"issue":"18","key":"1711_CR14","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMra1514296","volume":"375","author":"VA Boussiotis","year":"2016","unstructured":"Boussiotis VA (2016) Molecular and biochemical aspects of the PD-1 checkpoint pathway. N Engl J Med 375(18):1767\u20131778","journal-title":"N Engl J Med"},{"issue":"1","key":"1711_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/imr.12524","volume":"276","author":"L Ni","year":"2017","unstructured":"Ni L, Dong C (2017) New checkpoints in cancer immunotherapy. Immunol Rev 276(1):52\u201365","journal-title":"Immunol Rev"},{"key":"1711_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ebiom.2018.09.040","volume":"36","author":"ML Colli","year":"2018","unstructured":"Colli ML, Hill JLE, Marroqui L et al (2018) PD-L1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-alpha and-gamma via IRF1 induction. EBioMedicine 36:367\u2013375","journal-title":"EBioMedicine"},{"issue":"1","key":"1711_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.20022125","volume":"198","author":"M Ansari","year":"2003","unstructured":"Ansari M, Salama A, Chitnis T et al (2003) The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 198(1):63\u201369","journal-title":"J Exp Med"},{"issue":"9","key":"1711_CR18","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1210\/jc.2018-00728","volume":"103","author":"K Clotman","year":"2018","unstructured":"Clotman K, Janssens K, Specenier P, Weets I, De Block CEM (2018) Programmed cell death-1 inhibitor-induced type 1 diabetes mellitus. J Clin Endocrinol Metab 103(9):3144\u20133154","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"1711_CR19","doi-asserted-by":"publisher","first-page":"107827","DOI":"10.1016\/j.celrep.2020.107827","volume":"31","author":"K Pauken","year":"2020","unstructured":"Pauken K, Godec J, Odorizzi P et al (2020) The PD-1 pathway regulates development and function of memory CD8 T cells following respiratory viral infection. Cell Rep 31(13):107827","journal-title":"Cell Rep"},{"issue":"3","key":"1711_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/cei.12603","volume":"180","author":"R Fujisawa","year":"2015","unstructured":"Fujisawa R, Haseda F, Tsutsumi C et al (2015) Low programmed cell death-1 (PD-1) expression in peripheral CD4+T cells in Japanese patients with autoimmune type 1 diabetes. Clin Exp Immunol 180(3):452\u2013457","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"1711_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41574-020-0330-3","volume":"16","author":"F Wong","year":"2020","unstructured":"Wong F, Wen L (2020) A predictive CD8 T cell phenotype for T1DM progression. Nat Rev Endocrinol 16(4):198\u2013199","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1711_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11892-009-0020-y","volume":"9","author":"P Monti","year":"2009","unstructured":"Monti P, Heninger AK, Bonifacio E (2009) Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus. Curr Diab Rep 9(2):113\u2013118","journal-title":"Curr Diab Rep"},{"issue":"2","key":"1711_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cellimm.2011.12.008","volume":"273","author":"V Oling","year":"2012","unstructured":"Oling V, Reijonen H, Simell O, Knip M, Ilonen J (2012) Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes. Cell Immunol 273(2):133\u2013139","journal-title":"Cell Immunol"},{"issue":"9","key":"1711_CR24","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.2337\/db13-1952","volume":"63","author":"JW McGinty","year":"2014","unstructured":"McGinty JW, Chow IT, Greenbaum C, Odegard J, Kwok WW, James EA (2014) Recognition of posttranslationally modified GAD65 epitopes in subjects with type 1 diabetes. Diabetes 63(9):3033\u20133040","journal-title":"Diabetes"},{"issue":"11","key":"1711_CR25","doi-asserted-by":"publisher","first-page":"e112882","DOI":"10.1371\/journal.pone.0112882","volume":"9","author":"IT Chow","year":"2014","unstructured":"Chow IT, Yang J, Gates TJ et al (2014) Assessment of CD4+ T cell responses to glutamic acid decarboxylase 65 using DQ8 tetramers reveals a pathogenic role of GAD65 121\u2013140 and GAD65 250\u2013266 in T1D development. PLoS ONE 9(11):e112882","journal-title":"PLoS ONE"},{"issue":"4","key":"1711_CR26","doi-asserted-by":"publisher","first-page":"a007781","DOI":"10.1101\/cshperspect.a007781","volume":"2","author":"B Roep","year":"2012","unstructured":"Roep B, Peakman M (2012) Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harb Perspect Med 2(4):a007781","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"1711_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S2213-8587(13)70123-2","volume":"1","author":"KC Herold","year":"2013","unstructured":"Herold KC (2013) Restoring immune balance in type 1 diabetes. Lancet Diabetes Endocrinol 1(4):261\u2013263","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"328","key":"1711_CR28","doi-asserted-by":"publisher","first-page":"328rv4","DOI":"10.1126\/scitranslmed.aad7118","volume":"8","author":"W Zou","year":"2016","unstructured":"Zou W, Wolchok JD, Chen L (2016) PD-L1 (B7\u2013H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Science translational medicine 8(328):328rv4","journal-title":"Science translational medicine"},{"issue":"6","key":"1711_CR29","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.cell.2015.08.038","volume":"162","author":"D Littman","year":"2015","unstructured":"Littman D (2015) Releasing the brakes on cancer immunotherapy. Cell 162(6):1186\u20131190","journal-title":"Cell"},{"issue":"26","key":"1711_CR30","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1056\/NEJMe1205943","volume":"366","author":"A Ribas","year":"2012","unstructured":"Ribas A (2012) Tumor immunotherapy directed at PD-1. N Engl J Med 366(26):2517\u20132519","journal-title":"N Engl J Med"},{"issue":"8","key":"1711_CR31","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1172\/JCI120555","volume":"128","author":"L Yeo","year":"2018","unstructured":"Yeo L, Woodwyk A, Sood S et al (2018) Autoreactive T effector memory differentiation mirrors beta cell function in type 1 diabetes. J Clin Investig 128(8):3460\u20133474","journal-title":"J Clin Investig"},{"issue":"10","key":"1711_CR32","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.2337\/db14-0047","volume":"63","author":"T Orban","year":"2014","unstructured":"Orban T, Beam CA, Xu P et al (2014) Reduction in CD4 central memory T-cell subset in costimulation modulator abatacept-treated patients with recent-onset type 1 diabetes is associated with slower C-peptide decline. Diabetes 63(10):3449\u20133457","journal-title":"Diabetes"},{"issue":"3","key":"1711_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","volume":"18","author":"A Sharpe","year":"2018","unstructured":"Sharpe A, Pauken K (2018) The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol 18(3):153\u2013167","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"1711_CR34","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.2337\/dc15-0889","volume":"38","author":"M Mellati","year":"2015","unstructured":"Mellati M, Eaton KD, Brooks-Worrell BM et al (2015) Anti-PD-1 and Anti-PDL-1 monoclonal antibodies causing type 1 diabetes. Diabetes Care 38(9):e137\u2013e138","journal-title":"Diabetes Care"},{"issue":"33","key":"1711_CR35","doi-asserted-by":"publisher","first-page":"11823","DOI":"10.1073\/pnas.0505497102","volume":"102","author":"J Wang","year":"2015","unstructured":"Wang J, Yoshida T, Nakaki F, Hiai H, Okazaki T, Honjo T (2015) Establishment of NOD-Pdcd1-\/- mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci USA 102(33):11823\u201311828","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1711_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1158\/2326-6066.CIR-15-0210","volume":"4","author":"A Ribas","year":"2016","unstructured":"Ribas A, Shin D, Zaretsky J et al (2016) PD-1 blockade expands intratumoral memory T cells. Cancer Immunol Res 4(3):194\u2013203","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"1711_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ajpath.2016.11.002","volume":"187","author":"E Kuric","year":"2017","unstructured":"Kuric E, Seiron P, Krogvold L et al (2017) Demonstration of tissue resident memory CD8 T cells in insulitic lesions in adult patients with recent-onset type 1 diabetes. Am J Pathol 187(3):581\u2013588","journal-title":"Am J Pathol"},{"issue":"7077","key":"1711_CR38","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"D Barber","year":"2006","unstructured":"Barber D, Wherry E, Masopust D et al (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439(7077):682\u2013687","journal-title":"Nature"},{"issue":"19","key":"1711_CR39","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1073\/pnas.1705327114","volume":"114","author":"A Kamphorst","year":"2017","unstructured":"Kamphorst A, Pillai R, Yang S et al (2017) Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients. Proc Natl Acad Sci USA 114(19):4993\u20134998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1711_CR40","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.2337\/db07-1260","volume":"57","author":"C Wang","year":"2008","unstructured":"Wang C, Chou F, Chu C et al (2008) Protective role of programmed death 1 ligand 1 (PD-L1) in nonobese diabetic mice: the paradox in transgenic models. Diabetes 57(7):1861\u20131869","journal-title":"Diabetes"},{"issue":"1","key":"1711_CR41","doi-asserted-by":"publisher","first-page":"14928","DOI":"10.1038\/s41598-020-71946-3","volume":"10","author":"I Nojima","year":"2020","unstructured":"Nojima I, Eikawa S, Tomonobu N et al (2020) Dysfunction of CD8+PD-1+ T cells in type 2 diabetes caused by the impairment of metabolism-immune axis. Sci Rep 10(1):14928","journal-title":"Sci Rep"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01711-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-021-01711-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01711-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T18:05:56Z","timestamp":1627409156000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-021-01711-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1711"],"URL":"https:\/\/doi.org\/10.1007\/s00592-021-01711-z","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"type":"print","value":"0940-5429"},{"type":"electronic","value":"1432-5233"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"assertion":[{"value":"20 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}